Glycotope

Developer of Glyco-optimized antibodies and provider of contract research and manufacturing services.

placeBerlin, Berlin, Germany calendar_todayFounded 2001 groups116 employees language glycotope.com

Registered entities

Innovation

63 patent families (32 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Emerging technologies; filing pace slowing. Cited 5,620 times.

YearFilings
201520
201624
201731
201817
201915
202010
20217
20222
20238
20242
20253
20261

Investor mix

10 investors on record; lead investors include Eckert Life Science Accelerator, Octapharma.

Investor typeCountShare
Venture capital110%
Other / undisclosed990%
Coming soon